[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [9k=] --------------------------------------------------------------- [The Man, Whose Crypto Trades Have Soared 1,061% ... 1,934% ... and 18,235% - All in Less Than a Year, Reveals His Next Crypto Trade]( [Details here.]([aff_i?offer_...] --------------------------------------------------------------- September 7, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast]( [69616ec4-0f4...]( He predicted the 2020 crash a month before it happened… He predicted this year’s collapse back in January… And now, he’s issuing a brand-new warning – along with a unique solution. [Details here.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Dice Therapeutics, DICE]( Recent Analyst Action: Alex Thompson, analyst at Stifel Nicolaus, reiterates coverage on [Dice Therapeutics (DICE)](in the Healthcare sector with a Buy rating and a price target of $37.00 (1 day ago). - Recent Price: $20.38 - Average Analyst Price Target: $41.00 (101.18%) - Market Cap: $724.10M [TipRanks.com]( also reports that [Dice Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $41.00. The target pricing ranges from a high forecast of $46.00 down to a low forecast of $37.00. [Dice Therapeutics (DICE)](’s last closing price was $20.38 which would put the average price target at $41.00. Here are 3rd party ratings for [DICE](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 31% (78 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Warning: Why your IRA could crash on October 21st]( [53c3cb34-b61...]( China will attack Taiwan as soon as October 21st, 2022. The stock market will crash at least 35% when China makes their move. [Here are the 3 steps you can take to protect your retirement.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Wingstop, WING]( Recent Analyst Action: David Tarantino, analyst at Robert W. Baird, reiterates coverage on [Wingstop (WING)](in the Services sector with a Buy rating (2 weeks ago). - Recent Price: $135.44 - Average Analyst Price Target: $127.42 (-5.92%) - Market Cap: $3.95B [TipRanks.com]( also reports that [Wingstop](currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $127.42. The target pricing ranges from a high forecast of $150.00 down to a low forecast of $70.00. [Wingstop (WING)](’s last closing price was $135.44 which would put the average price target at $127.42. Here are 3rd party ratings for [WING](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 35% (165 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Portage Biotech Inc, PRTG]( Recent Analyst Action: Robert Burns, analyst at H.C. Wainwright, reiterates coverage on [Portage Biotech Inc (PRTG)](in the Healthcare sector with a Buy rating and a price target of $32.00 (1 week ago). - Recent Price: $9.365 - Average Analyst Price Target: $29.00 (209.66%) - Market Cap: $152.50M [TipRanks.com]( also reports that [Portage Biotech Inc](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $29.00. The target pricing ranges from a high forecast of $32.00 down to a low forecast of $26.00. [Portage Biotech Inc (PRTG)](’s last closing price was $9.365 which would put the average price target at $29.00. Here are 3rd party ratings for [PRTG](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 31% (78 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Lyft's Secret 7.48% Dividend Revealed]( [6e1b2dab-0cf...](This is the greatest discovery in my 31 year career as an income investor. I'm talking over 530 of Silicon Valley's hottest tech companies all rolled into a massive quarterly dividend. I'm revealing how you can secure a spot on their payout list. [Click here for the full uncensored details.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Lifestance Health Group, LFST]( Recent Analyst Action: Gary Taylor, analyst at Cowen & Co., reiterates coverage on [Lifestance Health Group (LFST)](in the Healthcare sector with a Buy rating and a price target of $10.00 (2 weeks ago). - Recent Price: $7.52 - Average Analyst Price Target: $10.00 (32.98%) - Market Cap: $2.73B [TipRanks.com]( also reports that [Lifestance Health Group](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $10.00. [Lifestance Health Group (LFST)](’s last closing price was $7.52 which would put the average price target at $10.00. Here are 3rd party ratings for [LFST](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 26% (187 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Entrada Therapeutics Inc, TRDA]( Recent Analyst Action: Chris Shibutani, analyst at Goldman Sachs, reiterates coverage on [Entrada Therapeutics Inc (TRDA)](in the Healthcare sector with a Hold rating and a price target of $13.00 (3 weeks ago). - Recent Price: $13.98 - Average Analyst Price Target: $13.00 (-7.01%) - Market Cap: $435.39M [TipRanks.com]( also reports that [Entrada Therapeutics Inc](currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $13.00. The target pricing ranges from a high forecast of $13.00 down to a low forecast of $13.00. [Entrada Therapeutics Inc (TRDA)](’s last closing price was $13.98 which would put the average price target at $13.00. Here are 3rd party ratings for [TRDA](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The #1 Stock Under $5]( [cbf0b3ac-70e...](Virginia Stock-Picking Millionaire Says It’s Not About Diversification! Buy one single $3 stock- that trades under a secret name- and it could help make your retirement. [His instructions are here.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Design Therapeutics, DSGN]( Recent Analyst Action: Leonid Timashev, analyst at RBC Capital, reiterates coverage on [Design Therapeutics (DSGN)](in the Healthcare sector with a Buy rating and a price target of $30.00 (3 weeks ago). - Recent Price: $22.69 - Average Analyst Price Target: $28.67 (26.36%) - Market Cap: $1.22B [TipRanks.com]( also reports that [Design Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $28.67. The target pricing ranges from a high forecast of $30.00 down to a low forecast of $26.00. [Design Therapeutics (DSGN)](’s last closing price was $22.69 which would put the average price target at $28.67. Here are 3rd party ratings for [DSGN](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 31% (78 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Akoya Biosciences, AKYA]( Recent Analyst Action: David Westenberg, analyst at Piper Sandler, reiterates coverage on [Akoya Biosciences (AKYA)](in the Healthcare sector with a Buy rating and a price target of $17.00 (3 weeks ago). - Recent Price: $12.93 - Average Analyst Price Target: $19.67 (52.13%) - Market Cap: $483.13M [TipRanks.com]( also reports that [Akoya Biosciences](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $19.67. The target pricing ranges from a high forecast of $22.00 down to a low forecast of $17.00. [Akoya Biosciences (AKYA)](’s last closing price was $12.93 which would put the average price target at $19.67. Here are 3rd party ratings for [AKYA](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Top 31% (78 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Dividends Paid Every Week- Regular as Clockwork]( [8b1be9c8-835...](I've been studying two new stocks carefully and they've both been paying dividends every week — regular as clockwork. One’s more aggressive and pays a nickel per share every Friday. The second is expected to yield 3% - 4% in the first year. And it also pays every Thursday. We can use these two new ETFs to pay for our groceries, gas or restaurant bills. Or, reinvest the dividends and quickly snowball our nest eggs to help meet our retirement goals. Today, I want to share this information with you, absolutely free. [Click here for details.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketMoversInsider.com Disclaimer This email/newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this email/newsletter is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this email/newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our email/newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketMoversInsider.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville | NC | 28115 MarketMoversInsider.com | 165 Lockerbie Lane | Moorsville | North Carolina | 28115 | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software